For example, in patients with germ cell tumors, serum prolactin (s-PRL) and thyroid function (TF) assays can be utilized to evaluate the degree of damage to the hypothalamus-pituitary axis and predict the need for post-treatment hormone replacement therapy in children with intracranial pure germ cell tumors (64). This evidence concerns the gene PRL and germ cell tumor.